COVID-19 vaccination: ERA-EDTA Immunology Working Group publishes recommendations
- 19 abr 2021
- 1 Min. de lectura
ERA-EDTA
Since people with autoimmune conditions requiring immunomodulatory therapy or chronic immunosuppression were excluded from COVID-19 vaccine clinical trials, patients have many questions for their nephrologists. The ERA-EDTA Immunonephrology Working Group (IWG) discuss frequently asked questions regarding safety and efficacy of COVID-19 vaccination in this group of patients.
Comentarios